Activities of red blood cell anti-oxidative enzymes (SOD, GPx) and total anti-oxidative capacity of serum (TAS) in men with coronary atherosclerosis and in healthy pilots

Medical Science Monitor

Volumn 11, Issue 9, 2005, Pages

  Zawadzka Bartczak, Ewelina ^a  

^a Polish Air Force Institute of Aviation Medicine Warsaw   (Poland)

Author keywords

Antioxidative enzymes; Coronary artery disease; Lipid concentration

Indexed keywords

CHOLESTEROL; ERYTHROCYTE ENZYME; GPX ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; SOD ENZYME; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DYSLIPIDEMIA; ENZYME ACTIVITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MALE; RISK FACTOR; SERUM;

ADULT; AEROSPACE MEDICINE; AGED; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 24944465982     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pawlicki L, Pawelski W, Kȩdziora J et al: Are oxidation-reduction balance disturbances a cause or a supporting factor in the atherogenic process? [Zaburzenia równowagi oksydoredukcyjnej przyczyna̧ czy czynnikiem podtrzymuja̧cym proces aterogenezy?]. Czynniki Ryzyka, 1998; 1: 21-28 (in Polish)
2. Domagała B, Dworski R: Lipid peroxides and antioxidants in plasma of healthy subjects and patients with atherosclerosis. [Nadtlenki lipidów i antyoksydanty w osoczu u ludzi zdrowych i u chorych z miażdż yca̧ tȩtnic]. Pol Arch Med Wewn, 1986; 75: 327-30 (in Polish)
3. Zawadzka-Bartczak E, Kopka L, Gancarz A: Antioxidants in fighter pilots. Aviat Space Environ Med, 2003; 74: 654-58
4. Steinberg D, Wirztum JL: Lipoproteins and Atherogenesis-Current Concepts. JAMA, 1990; 264: 3047-52
5. Esterbauer H, Dieber-Rotheneder M, Waeg G: Biochemical, Structural and Functional Properties of Oxidized Low-Density Lipoproteins. Chem Res Toxicol, 1990; 3: 77-92
6. Morin RJ, Peng SK: The Role of Cholesterol Oxidation Products in The Pathogenesis of Atherosclerosis. Ann Clin Lab Sci, 1989; 19: 225-37
7. Anderson TJ, Meredith IT, Charbonneau F: Endothelium dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation, 1996; 93: 1647-50
8. Liczmański AE: Oxygen toxicity, Part II: Defense mechanisms [Toksyczność tlenu Cz. II. Mechanizmy obronne]. Post Biochem, 1988; 34: 293-98 (in Polish)
9. Korantzopoulos P, Galaris D, Papaioannides D, Siogas K: The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit, 2003; 9(6): RA140-RA145
10. Beneditch A: Exercise and free radicals: effects of antioxidant vitamins. Med Sport Sci, 1991; 32: 59-78
11. Błaszczyk J, Buczyński A, Kȩdziora J: Blood platelet and erythrocyte superoxide dismutase (SOD-1) activity and malonyldialdehyde (MDA) concentrations in healthy men following submaximal physical exercise. Acta Physiol Pol, 1987; 38: 56-59
12. Błaszczyk J, Kȩdziora J, Lewicki R et al: The effectiveness of the glycolytic pathway in the red blood cells of healthy persons undergoing maximal physical effort [Wydajność szlaku glikolitycznego w krwinkach czerwonych u osób zdrowych poddanych maksymalnemu wysiłkowi fizycznemu]. Wychowanie Fizyczne I Sportowe, 1990; 34: 51-55 (in Polish)
13. Zachwieja J, Bobkowski W, Dobrowolska-Zachwieja A et al: Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome. Med Sci Monit, 2003; 9(6): CR287-CR291
14. Carpenter KL, Taylor SE et al: Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta, 1995; 1256: 141-45
15. Lombardi MP, Redeker EJ et al: Molecular genetic testing for familiar hypercholesterolemia: spectrum of LDL receptor gene mutations in The Netherlands. Clin Genet, 2000; 57: 116-24